Search results

Skip to results

Type

Type

Last updated

Last updated

Showing 1 result for isavuconazole

  1. What are the clinical and cost effectiveness, and the safety, of specific antifungal treatments for treating suspected or confirmed COVID-19-associated pulmonary aspergillosis (CAPA), and the optimal treatment duration? When should treatment be started, stopped or modified?

    and subgroups who have higher rates of COVID-19. I: voriconazole, isavuconazole, liposomal amphotericin B, posaconazole, echinocandins...

    Research recommendation
    Published
    9 March 2022